MLKMF Waldencast plc
Perfumes, Cosmetics & Other Toilet Preparations · OTC · SEC CIK 1840199
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY-0.7%
TTM net income YoY-441.3%
TTM EPS YoY-415.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin67.3%
Operating margin-80.0%
Net margin-84.4%
FCF margin-6.0%
EBITDA margin-78.8%
Returns
ROE-40.9%
ROA-26.7%
ROIC (approx.)-24.9%
Asset turnover0.32x
Leverage & solvency
Liabilities / assets33.0%
Debt / equity0.30x
Current ratio1.70x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.06x
Accruals ratio-25.2%
Payout ratio—
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $272.07M | $273.87M |
| Cost of revenue | $89.05M | $82.12M |
| Gross profit | $183.02M | $191.74M |
| SG&A expense | $247.98M | $245.30M |
| Operating income | -$217.54M | -$58.58M |
| Interest expense | — | $17.16M |
| Pretax income | -$262.25M | -$48.54M |
| Income tax | -$14.19M | $110,000 |
| Net income | -$229.75M | -$42.44M |
| EBITDA | -$214.44M | -$55.28M |
| EPS (basic) | -2.01 | -0.39 |
| EPS (diluted) | -2.01 | -0.39 |
| Weighted avg. shares (diluted) | 114.07M | 109.30M |
| Balance sheet | ||
| Cash & equivalents | $30.38M | $14.80M |
| Inventory | $54.61M | $53.10M |
| Current assets | $126.94M | $103.62M |
| PP&E, net | $6.24M | $5.83M |
| Goodwill | $177.57M | $329.59M |
| Intangibles | $427.10M | $526.44M |
| Total assets | $746.16M | $975.86M |
| Current liabilities | $74.55M | $76.89M |
| Short-term debt | $771,000 | $29.48M |
| Long-term debt | $135.75M | $137.14M |
| Total debt | $136.52M | $166.62M |
| Total liabilities | $246.06M | $245.92M |
| Shareholders' equity | $461.88M | $662.32M |
| Net debt | $106.14M | $151.81M |
| Cash flow statement | ||
| Operating cash flow | -$12.82M | -$8.82M |
| Capital expenditure | $3.43M | $2.71M |
| Free cash flow | -$16.25M | -$11.53M |
| Investing cash flow | $76.23M | -$2.92M |
| Financing cash flow | -$47.22M | $5.58M |
| Depreciation & amortization | $3.10M | $3.30M |
| Stock-based compensation | $11.80M | $9.39M |
Free plan shows the latest 2 periods; Pro shows all 5 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.